Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$432,380,783
+$118,061,931 QoQ
Shares Held
3,364,831
+28.8% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#77
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $2,885,207,124 across 10 Drug Manufacturers - General names. MRK ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
895,262 | $1,073,804,190 | |
| 2 | JNJ |
Johnson & Johnson
|
2,064,646 | $524,358,144 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
3,364,831 | $432,380,783 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,940,617 | $245,177,551 | |
| 5 | ABBV |
AbbVie Inc.
|
861,436 | $216,771,755 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
2,865,663 | $165,119,502 | |
| 7 | PFE |
Pfizer Inc
|
5,127,377 | $123,467,238 | |
| 8 | AMGN |
Amgen Inc
|
236,929 | $85,796,729 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $432,380,783 | 3,364,831 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $314,318,852 | 2,613,009 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $193,493,458 | 1,838,243 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $232,656,058 | 2,772,025 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $249,492,450 | 3,151,749 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $234,755,162 | 2,615,365 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $265,767,982 | 2,671,572 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $420,945,911 | 3,706,815 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $507,436,763 | 4,098,843 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $650,650,464 | 4,931,038 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $555,478,376 | 5,095,197 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $555,774,133 | 5,398,486 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $608,739,483 | 5,275,496 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $573,949,793 | 5,394,772 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $539,492,599 | 4,862,484 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $412,624,775 | 4,791,277 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $393,992,887 | 4,321,519 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $160,717,488 | 1,958,775 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $109,296,227 | 1,426,099 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $205,923,528 | 2,741,626 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $229,444,986 | 2,950,302 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $268,310,579 | 3,480,483 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $320,019,043 | 3,912,215 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $343,314,614 | 4,138,812 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $362,505,643 | 4,687,773 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $398,967,279 | 5,185,436 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||